Mutual of America Capital Management LLC Has $3.19 Million Stock Holdings in Teleflex Incorporated $TFX

Mutual of America Capital Management LLC cut its holdings in Teleflex Incorporated (NYSE:TFX) by 7.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 26,920 shares of the medical technology company’s stock after selling 2,201 shares during the quarter. Mutual of America Capital Management LLC owned about 0.06% of Teleflex worth $3,186,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Teacher Retirement System of Texas acquired a new stake in Teleflex in the first quarter valued at approximately $1,242,000. Amalgamated Bank lifted its stake in shares of Teleflex by 56.9% in the first quarter. Amalgamated Bank now owns 14,046 shares of the medical technology company’s stock worth $1,941,000 after buying an additional 5,095 shares during the last quarter. New York State Teachers Retirement System lifted its stake in shares of Teleflex by 13.9% in the first quarter. New York State Teachers Retirement System now owns 45,063 shares of the medical technology company’s stock worth $6,227,000 after buying an additional 5,482 shares during the last quarter. NorthCrest Asset Manangement LLC acquired a new stake in shares of Teleflex in the second quarter worth $299,000. Finally, Brown Advisory Inc. lifted its stake in shares of Teleflex by 34.2% in the first quarter. Brown Advisory Inc. now owns 2,524 shares of the medical technology company’s stock worth $349,000 after buying an additional 643 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Down 0.5%

Shares of TFX stock opened at $132.06 on Friday. Teleflex Incorporated has a 52-week low of $108.90 and a 52-week high of $239.46. The stock has a market cap of $5.84 billion, a price-to-earnings ratio of 31.07, a P/E/G ratio of 1.85 and a beta of 1.05. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The firm has a fifty day moving average of $126.06 and a 200-day moving average of $123.65.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company had revenue of $780.90 million during the quarter, compared to analysts’ expectations of $771.53 million. During the same quarter in the prior year, the company posted $3.42 EPS. The business’s revenue was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, equities research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Friday, August 15th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio is currently 32.00%.

Insider Activity

In other Teleflex news, Director Gretchen R. Haggerty bought 500 shares of the business’s stock in a transaction on Wednesday, August 6th. The shares were bought at an average cost of $114.75 per share, for a total transaction of $57,375.00. Following the transaction, the director owned 6,305 shares in the company, valued at approximately $723,498.75. This trade represents a 8.61% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Liam Kelly bought 1,500 shares of the business’s stock in a transaction on Tuesday, August 5th. The shares were acquired at an average price of $115.07 per share, for a total transaction of $172,605.00. Following the completion of the transaction, the chief executive officer owned 45,267 shares in the company, valued at approximately $5,208,873.69. This trade represents a 3.43% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 5,500 shares of company stock worth $633,590. 1.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Mizuho boosted their price objective on shares of Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, August 1st. Wall Street Zen cut shares of Teleflex from a “strong-buy” rating to a “buy” rating in a research note on Monday, September 15th. Wells Fargo & Company reduced their price objective on shares of Teleflex from $137.00 to $131.00 and set an “equal weight” rating for the company in a research note on Friday, August 1st. Zacks Research cut shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Teleflex in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Reduce” and a consensus price target of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.